Novartis Battens Down Hatches Over Falsified Zolgensma Data

 
• By Kevin Grogan

The Swiss major believes it responded in a timely fashion to data manipulation issues associated with its closely watched gene therapy but CEO Vas Narasimhan's bid to rebuild trust with society has taken a hit.

Spartan_Defense
Novartis defends its actions over Zolgensma data probe • Source: Shutterstock

More from Leadership

More from Scrip